| Literature DB >> 32230939 |
Abstract
This study examined the effect of lifestyle interventions on cardiovascular disease risk factors among workers. The study comprised a systematic review and meta-analysis of controlled trials. Relevant controlled trials were searched, with selections based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Risk of bias was assessed using the Scottish Intercollegiate Guidelines Network (SIGN). Of 1174 identified publications, one low-quality study was excluded. Finally, 10 were analyzed. The effect sizes were analyzed for heterogeneity, and random effect models (Hedge's g) were used. A subgroup analysis was performed on the follow-up point of intervention (≤ 12 months vs. > 12 months). Publication bias was also analyzed. Interventions were effective for systolic (g = 0.66, 95% CI: 0.27-1.60) and diastolic blood pressure (g = 0.63, 95% CI: 0.21-1.06), and BMI (g = 0.71, 95% CI: 0.15-1.11). Interventions were ineffective for weight (g = 0.18, 95% CI: -0.04, 0.40) and LDL-cholesterol (g = 0.46, 95% CI: -0.02, 0.93). There was high heterogeneity between studies (I2 =78.45 to I2 = 94.61). There was no statistically significant publication bias, except for systolic blood pressure. Interventions to reduce risk of cardiovascular disease risk might be effective in improving physical outcomes, but additional high-quality trials are needed in the future.Entities:
Keywords: cardiovascular disease; intervention study; meta-analysis; systematic review; workers
Year: 2020 PMID: 32230939 PMCID: PMC7177901 DOI: 10.3390/ijerph17072267
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram of study selection.
General Characteristics of the Studies.
| 1st Author (yr); Ref country | Design | Participants | Settings | No of Participants | Age(yr) | Intervention | Session/ | Length Time | Duration (Months)/ | Outcomes | Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cambein [ | 2-arm RCT | Civil servants | Administration department | Exp = 663 | Exp 29 ± 3 | I: Individual lifestyle change program: diet, smoking, physical activity using audio and visual materials | Not reported/ | Not reported | 12 months/ | Ht, BP(S), Smoking | - |
| Crowley [ | 2-arm | African Americans with type 2 DM | 2 clinics | Exp = 182 | Exp 57 ± 12 | I: Telephone-based nurse-delivered intervention for DM self-management and medication adherence | Total 12, | 17.1 ± 7.3 | 12 months/Baseline, | Primary: BP(S), HbA1c, LDL-C | + |
| Dekkers | 3-arm | Adults with over-weight | 7 companies | Exp1 = 91 | Exp1 43 ± 10 | I: Distance-counseling lifestyle intervention by dietician and movement scientists for weight, physical activity and healthy diet | Not reported, | Not reported | 6 months/ | BP(S/D), BMI, Wt. Ht, WC, TC, | ++ |
| Gemson [ | Quasi-experimental | Hypertension adults Employees (BP ≥ 140 or ≥ 90) | 5 sites, | Exp = 47 | Exp 45 ± 9 | I: Tailored blood pressure and weight reduction program by nurse based on BP/BMI measuring + pedometer | Not available/ | Not available | 12 months/ | BP(S/D), BMI, Wt. physical activity, and diet and nutrition behaviors (self-reported) | + |
| Hardcastle [ | 2 -arm | Adults with CVD risk factors | Primary care center | Exp = 203 | Exp 50 ± 1 | I: Individual motivational intervention by physical activity specialist and dietician for physical activity and nutrition | Total 5, | 20–30 | 6 months/ | BP(S/D), BMI, Wt, TC, HDL/LDL-C, TG, Physical activity, | + |
| Kang [ | 3 -arm | Male workers with DM risk factors (FPG ≥ 5.6 mmol) | Hospital | Exp1 = 25 | Exp1 46 ± 6 | I: Lifestyle intervention for main intervention (3 months) + e-mail nutrition follows- up | 5 (counseling)/ | 20-30/ | 12 months/ | BP(S/D), BMI, Wt, TC, HDL/LDL-C, WC, HbA1c, | + |
| Muto [ | 2 -arm | Blue-collar male workers with at least one abnormality in CVD risk factors | Building maintenance company’s worksite branches | Exp = 152 | Exp 42 ± 5 | I: Diet and physical activity intervention by health providers (physician, exercise trainer, and coordinators). Individual, group discussion, practice, etc. | Not available/ | 4 days, | 12 months/ | BP(S/D), BMI, Wt TC, | + |
| Proper [ | 2-arm RCT | Office employees | 3 municipal service | Exp = 131 | Exp 44 ± 1 | I: Individual counselling on physical activity, nutrition and lifestyle factors; Individual based on PACE protocol | 7/ | 20 | 9 months/ | Primary: Energy expenditure, Sport and Leisure-time index, Submaximal HR, | ++ |
| Racette [ | 2 -arm | Employees with smoke, pre-existing disease (hypertension, diabetes), and medication use | 2 Medical center worksites | Exp = 84 | Overall 45 ± 9/ | I: Assessment + physical activity and dietary intervention, individual goal setting, group discussion, etc. | Not reported/ | Not reported | 12 months/ | BMI, Wt, BP (S/D), TC, HDL/LDL– C, | + |
| Salinardi [ | 2 -arm | Employees with BMI ≥ 25 kg/m2 | 4 worksites | Exp = 94 | Exp 45 ± 1 | I: Group-based multi-component lifestyle intervention on weight loss and CVD risk factors prevention | 19/ | 60 | 6 months/ | Primary: Wt | + |
| Ursua [ | 2 -arm | Filipino Americans with hypertension (BP ≥ 140 or ≥ 90) | A metropolitan | Exp = 112 | Exp 54 ± 10 | I: CHW led education by Filipino immigrants. Mixed individual and group activities | 8 | 90 | 4 months/ | BP (S/D) | + |
Note: BMI: body weight index, BP(S): blood pressure (systolic), BP (D): blood pressure (diastolic), C: control, FB: fasting blood, I: intervention, LDL-C: low density lipoprotein cholesterol, HDL-C: high density lipoprotein cholesterol, TC: total cholesterol, Wt: weight.
Study quality ratings.
| Controlled Trial | Cambein [ | Crowley [ | Dekkers | Gemson [ | Hardcastle [ | Kang [ | Muto [ | Proper [ | Racette [ | Salinardi | Ursua [ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 The study addresses an appropriate and clearly focused question. | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 1.2 The assignment of subjects to treatment groups is randomized. | Y | Y | Y | N/A | Y | Y | Y | Y | Y | Y | Y |
| 1.3 An adequate concealment method is used. | N | N | Y | N/A | Y | N | N | Y | N | N | N |
| 1.4 The design keeps subjects and investigators ‘blind’ about treatment allocation. | N | Y | Y | N/A | Y | ? | N | Y | N | N | N |
| 1.5 The treatment and control groups are similar at the start of the trial. | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 1.6 The only difference between groups is the treatment under investigation. | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 1.7 All relevant outcomes are measured in a standard, valid, and reliable way. | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 1.8 What percentage of the individuals or clusters recruited into each treatment arm of the study dropped out before the study was completed? | Overall | Overall | Overall | Overall | Overall | 8.0%* | Overall | Overall | Overall | Overall | Overall 40.7% |
| 1.9 All the subjects are analyzed in the groups to which they were randomly allocated (often referred to as intention to treat analysis). | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 1.10 Where the study is carried out at more than one site, results are comparable for all sites. | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Overall assessment of the study | - | + | ++ | + | ++ | + | + | ++ | + | + | + |
Y = YES; N = No; CS = cannot say; NA = Not applied; * = intervention group.
Effect size at the final point, at each point for outcomes.
| Outcomes | Final Time Point | T1 (12 months <) | T2 (12 months ≥) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Size | Heterogeneity | Effect Size | Heterogeneity | Effect Size | Heterogeneity | ||||||||||
| No. of Studies | Hedges’ | 95% CI | I2 | P | No. of Studies | Hedges’ | 95% CI | I2 | P | No. of Studies | Hedges’ | 95% CI | I2 | P | |
| SBP | 10 | 0.66 | 0.27, 1.60 | 94.20 | 0.000 | 6 | 1.02 | 0.33, 1.70 | 96.63 | 0.000 | 7 | 0.20 | 0.10, 0.31 | 2.92 | 0.41 |
| DBP | 9 | 0.63 | 0.21, 1.06 | 93.73 | 0.000 | 6 | 0.91 | 0.27, 1.54 | 96.12 | 0.000 | 6 | 0.23 | 0.11, 0.35 | 0.00 | 0.60 |
| BMI | 6 | 0.71 | 0.15, 1.26 | 94.61 | 0.000 | 4 | 1.11 | 0.22, 2.01 | 97.08 | 0.000 | 4 | 0.37 | 0.25, 0.51 | 45.39 | 0.120 |
| Weight | 6 | 0.19 | −0.78, 0.46 | 78.45 | 0.000 | 4 | 0.16 | −0.29, 0.61 | 87.80 | 0.000 | 6 | 0.19 | −0.08, 0.46 | 78.45 | 0.000 |
| LDL | 5 | 0.46 | −0.02, 0.93 | 90.83 | 0.000 | 2 | 1.28 | −0.96, 3.52 | 97.78 | 0.000 | 4 | 0.10 | −0.04, 0.23 | 0.94 | 0.000 |
Figure 2The effect of the intervention. (A) Systolic blood pressure at final point; (B) Diastolic blood pressure at final point; (C) BMI at final point; (D)The effect of the intervention on systolic blood pressure < 12 m; E1 = Experimental group 1; E2 = Experimental group 2.
Figure 3Publication bias at the final point. (A) Systolic blood pressure; (B) Diastolic blood pressure; (C) BMI; (D) Weight; (E) LDL cholesterol.
Results of publication bias by Egger’s regression test at the final point.
| Outcomes | At the Final Point | ||
|---|---|---|---|
| No. of Studies | Egger’s Regression | ||
| t | |||
| SBP | 10 | 2.54 | 0.029 |
| DBP | 9 | 2.24 | 0.052 |
| BMI | 6 | 1.17 | 0.292 |
| Weight | 6 | 1.52 | 0.178 |
| LDL | 5 | 1.82 | 0.143 |